Participated · Seed · Dec 2025

Punto Health is developing a dementia care platform that combines speech-based digital biomarkers with personalized daily care plans and clinician dashboards to shift cognitive care toward earlier identification and proactive, day-to-day support. The system forms a connected ecosystem that guides patients and carers while streamlining monitoring and care coordination for clinicians. Over the past year, the team co-designed and clinically validated the product with partners such as Ace Alzheimer Center Barcelona, several NHS Foundation Trusts, and multiple Spanish hospitals, reaching more than 2,000 individuals in the process. Feedback from these patients, carers, and clinicians has shaped product features aimed at usability and continuous engagement. With fresh seed capital, the company plans to scale its technology, expand hiring in London and Barcelona, and widen access to proactive dementia care for additional families. Financially, Punto Health has secured $2.7 million to fund these growth initiatives. The company is led by co-founder and CEO Anna Muñoz Farré.

Led · Seed · Nov 2023

Toddl.co offers an all-in-one, cloud-based SaaS platform tailored for organizers of kids’ activities, handling bookings, payments and client management. The software is integrated with a toddl.co marketplace to help educators reach new customers. The product is positioned as the first SaaS platform in Europe specifically for this market. Founded in 2021 by Stephanie Meagher and Lorin May, the company aims to free up time for educators to focus on families. Toddl.co will use its recent funding to accelerate product development, expand sales and marketing, and support international expansion. The company closed a €500K pre-seed round that includes a €195K ENISA loan, indicating early-stage external financing.

Participated · Equity · Nov 2023

Adaion develops a data and AI platform that integrates sensorization and network topology into a unified model to monitor, clean, visualize and enrich distribution-grid data in real time. The company markets its "Neural Grids," an AI-driven layer and digital-twin capability that learns and adapts to predict and prevent grid problems and model network capacity. Its solution aims to give distribution utilities visibility in low-voltage networks, reduce congestion, and accelerate integration of renewable generation. With plans to roll out internationally, Adaion will use the recent funding to expand abroad and implement its Neural Grids at scale. The startup was founded in 2021 and today has a team of about 20 experts in data science, AI, and electrical networks. Financially, Adaion closed its first investment round totaling €2.6 million to support these initiatives.

Led · Series A · Sep 2023

Erudit connects to apps companies already use (Slack, Microsoft Teams, Zoom) and runs collected data through AI algorithms to produce real-time people-analytics scores such as alignment, autonomy, engagement and satisfaction. The company says its models are trained by psychologists to extract and classify sentiment and to detect trigger phrases indicating stress or job searching. Erudit anonymizes chat data, allows customers to exclude individual employees, teams or departments, and processes checkpoints on a daily basis rather than in real time. The platform is used by “dozens” of businesses today. Erudit has 20 employees and expects to expand its team in the months ahead, particularly in customer support, customer success and sales. The product aims to replace lagging indicators like surveys, but the company and critics acknowledge privacy, bias and interpretation risks with monitoring employee communications. Erudit has developed technology that applies artificial intelligence and natural language processing to improve corporate talent management, studying employee personality, mental health and organizational climate. The company has a presence in the United States and its team comprises around 30 people from diverse sectors and experience areas. Erudit was founded by Alejandro Martínez Agenjo and Ricardo Michel Reyes and earned the Banco Santander and Universidad Europea award for best young social entrepreneurs in 2018. Early support came from IBM and Wayra (Telefónica’s accelerator), and the company has closed several financing rounds to date. The firm is exploring commercial opportunities with partners in areas such as M&A, culture and engagement, internal communication and reputational risk control through collaboration with investors. Erudit provides an AI-driven platform that passively collects data from business tools like Slack, GSuite, and Microsoft 365 and uses a proprietary algorithm to assess employee sentiment and burnout. The company launched an initial version of its platform in March 2021 and has seen rapid growth since. Erudit has 26 employees and currently has six remote openings, and has made several strategic hires including a head of partnerships and a CMO who previously led marketing at Cabify. The team has opened a new revenue channel through partnerships that enable reselling of its AI products. Financially, Erudit recently closed a $3.5M late seed round and plans to open a Series A before the end of the second quarter. Co‑founders Alejandro Martinez Agenjo and Ricardo Michel Reyes lead the company and have emphasized using the product to provide tangible human-capital metrics for executives and investors.

Participated · Series A · Sep 2023

IOMED develops AI-powered technology to activate healthcare data across hospitals, unlocking both structured and unstructured sources via a Natural Language Processing system. Its platform transforms data into the OMOP Common Data Model and keeps data inside hospital facilities using a Federated Data Model. The company positions itself as a strategic ally for real-world data–driven healthcare ecosystems and says its mission is to drive a better future for healthcare through AI. IOMED plans international expansion and to consolidate its market position as part of this next growth stage. It has recently strengthened its business and technology leadership team and updated its brand image to reflect its maturity and innovation. Financially, IOMED closed a €10 million Series A and received a nearly €1 million grant from red.es for an AI R&D project. IOMED builds AI and natural language processing software that transforms free-text electronic health records into coded, structured data for clinical research. Its product suite includes locally installed GDPR-compliant data storage, software for observational studies, and a patient-matching network for clinical trials. The company currently works with hospitals across Spain, running projects in 27 medical centres including Vall d'Hebron, Hospital del Mar and Cruces-Biocruces Bizkaia University Hospital. IOMED plans to expand throughout Spain and into Germany and the UK using proceeds from its latest raise. It raised €2 million in the most recent funding round. The startup was founded in 2016 by Álvaro Abella, Gabriel de Maeztu and Javier de Oca and is based in Barcelona. IOMED Medical Solutions develops Medical Language API (MEL), a software that uses natural-language understanding to extract clinically relevant concepts from physicians' electronic records and store them in structured databases. MEL launched to market in 2017 and the company operates under the umbrella of IQS Tech Factory, Spain's first industrial startup accelerator. IOMED applies big‑data analytics to the structured outputs to build predictive models for clinical events such as future hospital readmissions. The technology began implementation in the traumatology area of Hospital Universitario Vall d’Hebron in 2018. The company closed a €500,000 financing round in 2018 that will be used to expand its team and broaden deployment of its technology into new areas. IOMED positions its solution as a way for hospitals to anticipate events, improve patient care and generate operational efficiencies.